2IA Stock Chart & Stats
€0.01
<€0.01(20.00%)
At close: 4:00 PM EDT
€0.01
<€0.01(20.00%)
Day’s Range― - ―
52-Week Range€0.01 - €0.01
Previous CloseN/A
Volume6.00K
Average Volume (3M)45.63K
Market Cap
€21.64M
Enterprise Value€371.90
Total Cash (Recent Filing)€8.26M
Total Debt (Recent Filing)€238.68M
Price to Earnings (P/E)―
Beta-5.32
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,974,811,000
10 Day Avg. Volume45,625
30 Day Avg. Volume45,625
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.24
Price to Sales (P/S)0.17
P/FCF Ratio-1.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Licensed Cannabis PlatformThe company has historically operated across multiple licensed cannabis activities, providing vertical capabilities from cultivation through retail. This platform can support product control and market access if restructuring restores operational continuity.
Positive Gross MarginA positive gross margin indicates the core products still generate contribution before operating costs, while the improvement versus 2025 suggests some underlying economics remain viable. Sustaining this margin could aid recovery if revenue stabilizes.
Established Operating FootprintThe workforce and historical multi-function presence indicate an established operating platform rather than a purely prospective business. That infrastructure may provide useful capabilities for rebuilding operations, though execution remains dependent on financial stabilization.
Bears Say
Severe Revenue ContractionA sharp and sustained top-line decline weakens operating leverage, reduces the company’s ability to absorb fixed costs, and can erode market presence. Recovery would require renewed demand, stable operations, and successful execution across its regulated markets.
Persistent UnprofitabilityDeep losses and negative operating profit show that gross profit is not covering the broader cost base. Unless management materially improves scale, expenses, or pricing, the business is likely to remain dependent on external funding.
Stressed Balance Sheet And Cash BurnNegative equity, high debt relative to assets, and materially negative free cash flow leave limited financial flexibility. This combination raises refinancing and solvency risk while increasing the need for capital or restructuring to sustain operations.
iAnthus Capital Holdings News
2IA FAQ
What was iAnthus Capital Holdings Inc’s price range in the past 12 months?
iAnthus Capital Holdings Inc lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is iAnthus Capital Holdings Inc’s market cap?
iAnthus Capital Holdings Inc’s market cap is €21.64M.
When is iAnthus Capital Holdings Inc’s upcoming earnings report date?
iAnthus Capital Holdings Inc’s upcoming earnings report date is Nov 11, 2026 which is in 74 days.
How were iAnthus Capital Holdings Inc’s earnings last quarter?
iAnthus Capital Holdings Inc released its earnings results on Aug 12, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is iAnthus Capital Holdings Inc overvalued?
According to Wall Street analysts iAnthus Capital Holdings Inc’s price is currently Overvalued.
Does iAnthus Capital Holdings Inc pay dividends?
iAnthus Capital Holdings Inc does not currently pay dividends.
What is iAnthus Capital Holdings Inc’s EPS estimate?
iAnthus Capital Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iAnthus Capital Holdings Inc have?
iAnthus Capital Holdings Inc has 6,974,811,000 shares outstanding.
What happened to iAnthus Capital Holdings Inc’s price movement after its last earnings report?
iAnthus Capital Holdings Inc reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of iAnthus Capital Holdings Inc?
Currently, no hedge funds are holding shares in DE:2IA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iAnthus Capital Holdings Inc
iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.